Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
An amendment to this paper has been published and can be accessed via the original article.
Bibliographic Details
| Main Authors: |
Tsutomu Takeuchi,
Yoshiya Tanaka,
Sakae Tanaka,
Atsushi Kawakami,
Yeong-Wook Song,
Yi-Hsing Chen,
Mitsuhiro Rokuda,
Hiroyuki Izutsu,
Satoshi Ushijima,
Yuichiro Kaneko,
Yoshihiro Nakashima,
Teruaki Shiomi,
Emi Yamada |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
BMC
2020-06-01
|
|---|
| Series: | Arthritis Research & Therapy
|
|---|
| Online Access: | http://link.springer.com/article/10.1186/s13075-020-02247-3
|
|---|
